Summary:
ZA-203: A randomized, double blind, placebo and active controlled, parallel, multi-center phase iib study to evaluate normalization of morning testosterone levels in men with secondary hypogonadism with confirmed morning testosterone levels <250 ng/dl that wish to preserve their reproductive status and are not currently being treated with topical testosterone.
Qualified Participants Must:
• Be 21 to 65 years of age
•
Have or have symptoms of secondary hypogonadism or low morning testosterone
•
Be willing to use a double barrier form of birth control for the length of the study
Qualified Participants May Receive:
Study related lab work,medical care and medications free of charge. You may also be compensated for your participation.